Genentech USA Inc - Strategic SWOT Analysis Review

Genentech USA Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the companys key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy GlobalDatas summarization of the companys business strategy.
- SWOT analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list of key locations and subsidiaries of the company, including contact details.

Highlights

Genentech USA Inc (Genentech), a subsidiary of F. Hoffmann-La Roche Ltd, is a biotechnology company that discovers, develops, manufactures and commercializes medicines to address serious medical needs. It offers drugs in various therapeutic areas including oncology, immunology, ophthalmology, metabolism, neurology and infectious disease, among others. Its pipeline products include Emicizumab (RG6013, ACE910), a bispecific monoclonal antibody used to replace the function of protein in the blood clotting process; and Entrectinib (RXDX-101, RG6268), a CNS-active tyrosine-kinase inhibitor intended for the treatment of non-small cell lung cancer; among others. The company has partnership with BioLineRx, Charles River Laboratories International and Amunix, among others. Genentech is headquartered in South San Francisco, California, the US.

Genentech USA Inc Key Recent Developments

Oct 27,2020: Lodo Therapeutics achieves second preclinical milestone in its strategic collaboration with Genentech
Oct 06,2020: Imbio Partners with Genentech to Develop Imaging Diagnostics for Lung Diseases
Oct 02,2020: Vaccibody, Genentech partner to develop cancer vaccines
Oct 01,2020: Vaccibody announces update on expanded R&D focus and strategy
Sep 22,2020: Scenic Biotech forms drug development alliance with Genentech

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this reports analysis of the companys business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors business structure and strategies with GlobalDatas detailed SWOT analysis. In this, the companys core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this reports detailed insight into the companys strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.



Section 1 - About the Company
Genentech USA Inc - Key Facts
Genentech USA Inc - Key Employees
Genentech USA Inc - Key Employee Biographies
Genentech USA Inc - Major Products and Services
Genentech USA Inc - History
Genentech USA Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 Company Analysis
Company Overview
Genentech USA Inc - Business Description
Genentech USA Inc - SWOT Analysis
SWOT Analysis - Overview
Genentech USA Inc - Strengths
Genentech USA Inc - Weaknesses
Genentech USA Inc - Opportunities
Genentech USA Inc - Threats
Genentech USA Inc - Key Competitors
Section 3 Companys Lifesciences Financial Deals and Alliances
Genentech USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Genentech USA Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Genentech USA Inc, Recent Deals Summary
Section 4 Companys Recent Developments
Oct 27, 2020: Lodo Therapeutics achieves second preclinical milestone in its strategic collaboration with Genentech
Oct 06, 2020: Imbio Partners with Genentech to Develop Imaging Diagnostics for Lung Diseases
Oct 02, 2020: Vaccibody, Genentech partner to develop cancer vaccines
Oct 01, 2020: Vaccibody announces update on expanded R&D focus and strategy
Sep 22, 2020: Scenic Biotech forms drug development alliance with Genentech
Sep 10, 2020: French authority orders 444m fine on Novartis, Roche over Lucentis
Jul 30, 2020: Roche and UCB partner to develop antibody therapy for Alzheimers
Jul 24, 2020: US DoJ calls for increased Covid-19 monoclonal antibody production
Jul 23, 2020: Department Of Justice issues business review letter to monoclonal antibody manufacturers to expedite and increase the production of Covid-19 Mab treatments
Jul 22, 2020: Alzheimers Drug Discovery Foundation (ADDF) announces new biobank sharing program to accelerate Alzheimers disease biomarker research
Section 5 Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables


Genentech USA Inc, Key Facts
Genentech USA Inc, Key Employees
Genentech USA Inc, Key Employee Biographies
Genentech USA Inc, Major Products and Services
Genentech USA Inc, History
Genentech USA Inc, Other Locations
Genentech USA Inc, Key Competitors
Genentech USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Genentech USA Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Genentech USA Inc, Recent Deals Summary

List Of Figures


Genentech USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Genentech USA Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

Genentech USA Inc - Strategic SWOT Analysis Review

Genentech USA Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information

USD 125 View Report

Genentech Inc - Strategic SWOT Analysis Review

Genentech Inc - Strategic SWOT Analysis Review

USD 125 View Report

ACUTRONIC USA Inc - Strategy, SWOT and Corporate Finance Report

ACUTRONIC USA Inc - Strategy, SWOT and Corporate Finance ReportACUTRONIC USA Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report

USD 175 View Report

LOreal USA Inc - Strategic SWOT Analysis Review

LOreal USA Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information

USD 125 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available